Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $111.9100 (0.05%) ($109.5100 - $113.9900) on Wed. Jul. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.52% (three month average) | RSI | 54 | Latest Price | $111.9100(0.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.3% a day on average for past five trading days. | Weekly Trend | LGND advances 0.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.76% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) UNG(-3%) IYT(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.76% (StdDev 3.52%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
Resistance Level | $114.34 | 5 Day Moving Average | $112.48(-0.51%) | 10 Day Moving Average | $113(-0.96%) | 20 Day Moving Average | $114.34(-2.13%) | To recent high | -9.5% | To recent low | 63.9% | Market Cap | $1.799b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |